Astellas Pharma Canada, Inc.
Registration:
5
of
5
(2022-09-07
to
2023-03-16)
Details Regarding the Identified Subject Matter
|
Specific Topics of Lobbying Communications
|
Intended Outcomes
|
Associated Subject Matters
|
Seeking public listing and reimbursement of Astellas innovative medicines on BC formularies.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Health
|